Hyperliquid Strategies (NASDAQ:PURR) Upgraded by Wall Street Zen to “Hold” Rating

Hyperliquid Strategies (NASDAQ:PURR) was upgraded by stock analysts at Wall Street Zen to a “hold” rating in a research note issued to investors on Saturday.

A number of other analysts have also recently commented on the company. Chardan Capital lifted their target price on Hyperliquid Strategies from $8.15 to $8.45 and gave the stock a “buy” rating in a research report on Thursday, February 12th. Cantor Fitzgerald lifted their price target on Hyperliquid Strategies from $5.00 to $6.00 and gave the stock an “overweight” rating in a research report on Thursday, February 12th. Two equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Hyperliquid Strategies presently has an average rating of “Buy” and a consensus target price of $7.23.

Hyperliquid Strategies Price Performance

PURR stock opened at $4.29 on Friday. Hyperliquid Strategies has a twelve month low of $3.01 and a twelve month high of $5.78.

Hyperliquid Strategies (NASDAQ:PURR) last issued its earnings results on Wednesday, February 11th. The company reported ($7.43) earnings per share (EPS) for the quarter. The firm had revenue of $0.50 million for the quarter.

Institutional Trading of Hyperliquid Strategies

A number of hedge funds have recently added to or reduced their stakes in the stock. Boothbay Fund Management LLC purchased a new position in shares of Hyperliquid Strategies in the 4th quarter valued at approximately $40,000. XTX Topco Ltd acquired a new stake in shares of Hyperliquid Strategies during the fourth quarter worth $48,000. Squarepoint Ops LLC purchased a new position in Hyperliquid Strategies in the 4th quarter valued at $73,000. Millennium Management LLC acquired a new position in Hyperliquid Strategies in the 4th quarter valued at $87,000. Finally, Ikarian Capital LLC purchased a new position in Hyperliquid Strategies during the 4th quarter worth $107,000. 9.45% of the stock is owned by institutional investors and hedge funds.

About Hyperliquid Strategies

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.